4833M 15 500 (Metformin Hydrochloride and Pioglitazone Hydrochloride 500 mg / 15 mg)

Pill with imprint 4833M 15 500 is White, Capsule-shape and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 500 mg / 15 mg. It is supplied by Teva Pharmaceuticals USA.

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 500 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4833M 15 500

Metformin Hydrochloride and Pioglitazone Hydrochloride

Imprint

4833M 15 500

Strength

500 mg / 15 mg

Color

White

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Antidiabetic combinations

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Teva Pharmaceuticals USA

Inactive Ingredients

povidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), polyethylene glycol 8000, titanium dioxide, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00093-5049 (Discontinued)	Teva Pharmaceuticals USA, Inc.
64764-0155	Takeda Pharmaceutical Company Limited
42291-0693 (Discontinued)	AvKare, Inc.
54868-5500 (Discontinued)	Physicians Total Care Inc. (repackager)

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related Images for "4833M 15 500"

Actoplus Met

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer